ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

Inclusion Criteria:

• Pathogenic or likely pathogenic mutation in BAG3

• Medical history of diagnosis of DCM

• Stable combination of HF SoC medications

• Adequate acoustic windows for echocardiography

Exclusion Criteria:

• Presence of antibodies to AAV9

• Presence of a pathogenic or likely pathogenic variant in another gene where thatother gene is authoritatively recognized as causal for DCM.

• Decompensated HF

Note: Other inclusion and exclusion criteria may apply.